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ABSTRACT Inhaled hydrogen gas (H2) provides protection in rat models of human acute lung injury (ALI). We 
previously reported that biomarker imaging can detect oxidative stress and endothelial cell death in vivo in a rat 
model of ALI. Our objective was to evaluate the ability of 99mTc-hexamethylpropyleneamineoxime (HMPAO) 
and 99mTc-duramycin to track the effectiveness of H2therapy in vivo in the hyperoxia rat model of ALI. Rats were 
exposed to room air (normoxia), 98% O2+ 2% N2 (hyperoxia) or 98% O2 + 2% H2 (hyperoxia+H2) for up to 60 h. In 
vivo scintigraphy images were acquired following injection of 99mTc-HMPAO or 99mTc-duramycin. 
For hyperoxia rats, 99mTc-HMPAO and 99mTc-duramycin lung uptake increased in a time-dependent manner, 
reaching a maximum increase of 270% and 150% at 60 h, respectively. These increases were reduced to 120% 
and 70%, respectively, in hyperoxia+H2 rats. Hyperoxia exposure increased glutathione content in lung 
homogenate (36%) more than hyperoxia+H2 (21%), consistent with increases measured in 99mTc-HMPAO lung 
uptake. In 60-h hyperoxia rats, pleural effusion, which was undetectable in normoxia rats, averaged 9.3 
gram/rat, and lung tissue 3-nitrotyrosine expression increased by 790%. Increases were reduced by 69% and 
59%, respectively, in 60-h hyperoxia+H2 rats. This study detects and tracks the anti-oxidant and anti-apoptotic 
properties of H2 therapy in vivo after as early as 24 h of hyperoxia exposure. The results suggest the potential 
utility of these SPECT biomarkers for in vivoassessment of key cellular pathways in the pathogenesis of ALI and 
for monitoring responses to therapies. 
INTRODUCTION 
Acute lung injury (ALI) is one of the most frequent causes of admission to medical intensive care units (1, 2). Acute 
Respiratory Distress Syndrome (ARDS) occurs in ∼250,000 patients/year in the US, carries a mortality rate that 
may exceed 40%, lacks early detection tools, and has limited therapies (1, 2). The most common therapy is 
ventilation with high concentrations of oxygen (hyperoxia) (3). However, sustained exposure to high fractions of 
oxygen causes ARDS (4). Thus, the development of novel diagnostics and therapies for treating patients with 
ARDS is urgently needed. 
Recent preclinical studies have demonstrated that inhaled hydrogen gas (H2) at a concentration of ∼2% provides 
protection in lung injury animal models of human ALI/ARDS (e.g., ventilation-induced injury, transplant-induced 
ischemia-reperfusion injury, lipopolysaccharide, and hyperoxic injury) (5–10), attributed to its potent anti-oxidant, 
anti-apoptotic, and anti-inflammatory properties. H2 reduces the most damaging oxidants such as hydroxyl 
radical and peroxynitrite, but has no effect on superoxide, nitric oxide, or hydrogen peroxide and hence does 
not interfere with their role in cell signaling and/or immune response (5, 8). Additional studies have shown that 
the anti-apoptotic properties of H2 are associated with inhibition of caspase 3 activation (8). Moreover, H2 is 
highly diffusible (6, 8), and hence can readily reach subcellular compartments that are targets of oxidative stress, 
including mitochondria. 
Recently, we demonstrated the utility of single-photon emission computed tomography (SPECT) biomarker 
imaging to detect oxidative stress (using 99mTc-hexamethylpropyleneamine oxime [HMPAO]) and endothelial cell 
death (using 99mTc-duramycin) in lungs of rats exposed to high concentrations of O2 (hyperoxia) or treated with 
the endotoxin lipopolysaccharide as models of human ALI/ARDS (8, 11–13). Furthermore, we identified a strong 
correlation between 99mTc-HMPAO uptake and glutathione tissue content (12), as an indicator of oxidative stress, 
and between 99mTc-duramycin uptake and cleaved-caspase 3 as a marker of apoptosis (11, 14). The objective of this 
study was to evaluate the potential utility of 99mTc-HMPAO and 99mTc-duramycin to track the effectiveness of 
H2 therapy in vivo in the hyperoxia rat model of human ALI/ARDS. 
MATERIALS AND METHODS 
Materials 
HMPAO (Ceretec) was purchased in kit form from GE Healthcare (Arlington Heights, Ill), and technetium-labeled 
macroaggregated albumin (99mTc-MAA, particle sizes 20–40 μm) was purchased from Cardinal Health 
(Wauwatosa, Wis). Antibodies to 3-nitrotyrosine (3-NT) (Abcam, # ab52309), and keratin 4-hydroxynonenal (4-
HNE) (Abcam, # ab46545) were used with appropriate secondary antibodies (mouse 1:3,000 for 3-NT and rabbit 
1:3,000) to measure expression of 3-nitrotyrosine (3-NT) and 4-hydroxynonenal (4-HNE) in lung tissue 
homogenate. Diethyl maleate (DEM) and other reagent grade chemicals were purchased from Sigma–Aldrich (St. 
Louis, Mo). 
Rat model of human ALI/ARDS 
All treatment protocols were approved by the Institutional Animal Care and Use Committees of the Zablocki 
Veterans Affairs Medical Center, the Medical College of Wisconsin and Marquette University. 
For normoxia (control) rat studies, adult (68–77 days old) male Sprague–Dawley rats (Charles River; 351 ± 3 (SE) 
g, n = 42) were exposed to room air in chambers side by side with those exposed to hyperoxia. 
For hyperoxia studies, age- and weight-matched rats (341 ± 3 g, n = 77) were housed in a Plexiglass chamber and 
exposed to 98% O2 + 2% N2 (pure oxygen mixed with air) for 24, 48, or 60 h as previously described (12). To 
evaluate the therapeutic effect of 2% H2, age-matched rats (344 ± 3 g, n = 62) were housed similarly but exposed 
to 98% O2 + 2% H2 (Praxair Inc, Danbury, Conn) for 24, 48, or 60 h. For 
all hyperoxia and hyperoxia+H2 experiments, the O2 concentration in the chamber was measured using a DD103 
DrDAQ Oxygen Sensor (Pico Technology, Cambridgeshire, UK) and was determined to be > 96%. For 
the hyperoxia+H2 experiments, the H2concentration in the chamber was measured using a portable hydrogen 
detector (Model # 7200P, US Industrial Products Co, Cypress, Calif) and determined to be >1.8%. 
Lung wet-to-dry weight ratio, weight of pleural effusion 
Heart and lungs from a randomly selected subset of each group of rats were isolated as previously described (12). 
The lungs were dissected free of the heart, trachea and mainstem bronchi, and total lung wet weight was 
obtained. The left lung lobe was weighed and dried at 60oC for wet-to-dry weight ratio and the remaining lung 
lobes were used for the histological studies described below (12). 
For a subset of rats exposed to hyperoxia or hyperoxia+H2, pleural effusion within the chest cavity was 
determined by inserting cotton gauze into the chest cavity to absorb any pleural effusion (11). The gauze was 
weighed before and after use and the difference in weights was used to measure pleural effusion. 
Histology 
In a randomly selected subset of rats with normoxia (n = 4), 48-h hyperoxia (n = 5), 48-h hyperoxia+H2 (n = 5), 
60-h hyperoxia (n = 5), and 60-h hyperoxia+H2 (n = 4) lungs were fixed after inflation in 10% neutral buffered 
formalin (Fisher Scientific, Pittsburg, Pa) and embedded in paraffin. Whole-mount sections of lung were cut (4 
μm thick), processed and stained with hematoxylin and eosin (H&E, Richard Allan, Kalamazoo, Mich). Using high-
resolution jpeg images of the slides, an investigator masked to the treatment groups obtained 3 to 4 
representative images from preselected areas of the lung on each slide, avoiding large vessels, or airways at 
×100 (for neutrophils and edema) and ×400 (for alveolar septum thickness). These images were then scored 
independently and values for each rat averaged for a single “n.” We used a 0 to 2 scoring system for neutrophil 
influx, edema, and thickness of the diffusion barrier (Table 1) recommended by Matute-Bello et al. (15). 
 
TABLE 1. Endpoints for histological injury grading on a scale of 0–2 for each of the indices of injury, including 
neutrophilic influx, edema, and thickness of the alveolar septum 
 
Histology injury 
endpoint/score 
0 1 2 
Neutrophilic influx None to very rare Perivascular or peribronchiolar 
only 
Intra-alveolar and widely 
distributed 
Edema None to very rare Proteinacious material in < 5% 
and <20% field 
Proteinacious material in 
> 20% field 
Thickness of alveolar 
septum 
::: 1.8 x control 
thickness 
>1.8 but < 2.5 x control 
thickness 
>2.5 x control thickness 
 
Western blots 
Western blot analysis was carried out as previously described (16) on whole lung tissue homogenate (protein 
concentration 30 μg/μL) to quantify the expressions of 3-nitrotyrosine (3-NT) (17) and (4)-hydroxynonenal (4-
HNE) (18) as indicators of oxidative stress. The following primary antibodies (Abcam) were used: 3-NT ab52309 
and 4-HNE ab46545 with appropriate secondary antibodies. 
Bronchoalveolar lavage (BAL) 
Representative rats from normoxia, 48-h hyperoxia, and 48-h hyperoxia+H2 groups were anesthetized with 
Beuthanasia (40–50 mg/kg i.p.). The trachea was cannulated, the chest opened, and the heart and lungs were 
removed from the thoracic cavity. The lungs were infused through the trachea with 3 mL of ice-cold, Ca2+-free 
phosphate-buffered saline ex vivo(12). The solution was withdrawn and saved for analysis. The procedure was 
repeated with a second volume of 3 mL for a total instilled lavage of 6 mL. The returned BAL volume was 
measured and the cells resuspended by gentle agitation. An aliquot (1 mL) was removed for determination of 
total cell counts and protein concentration in the cell-free supernatant. The remainder of the sample was used 
for cytospin preparations. Cell counts were obtained by resuspending cell pellet from 1 mL after centrifugation 
at 1,000 g for 10 min in a known volume and counting with a hemocytometer (12). 
Mitochondrial membrane potential 
Representative rats from the normoxia, 48-h hyperoxia, and 48-h hyperoxia+H2 groups were anesthetized, and 
the lungs rapidly exposed and cleared of residual blood with 50 mL cold perfusion solution (physiologic saline 
buffered with 10 mM HEPES (pH 7.4) and containing 5.5 mM glucose) via the right ventricle. The lungs were then 
removed from the chest, trachea, large airways, and large vessels were removed, after which the peripheral lung 
was placed in an ice-cold homogenization buffer (pH 7.4) containing 10 mM HEPES, 200 mM mannitol, 70 mM 
sucrose, 1 mM EFTA, 2% fatty acid-free BSA, and protease inhibitor cocktail (50 μL/g lung tissue; set III, 
Calbiochem) and minced over ice. Lung tissue was homogenized using a Tissue Tearer Homogenizer. The 
resulting homogenate was then centrifuged (Sorvall Superspeed RC-5B, Norwalk, Conn) at 2,000 × g at 4°C for 15 
min. The supernatant was transferred to a clean tube and centrifuged at 17,800 × g at 4°C for 15 min. The 
resulting supernatant was discarded and the remaining pellet was resuspended in 5 mL ice-cold homogenization 
solution and centrifuged at 17,800 × g at 4°C for 15 min. The supernatant was discarded and the final pellet was 
resuspended in 0.3 to 4 mL ice-cold buffer (same as the homogenization buffer without BSA or the protease 
inhibitor cocktail) and stored on ice to be used for membrane potential studies. Mitochondrial protein was 
determined using the Pierce BCA protein assay with bovine serum albumin as the standard. 
Mitochondrial membrane potential (Δψm) studies were performed at room temperature using a Photon 
Technology International (PTI) QuantaMaster fluorometer (HORIBA Scientific, Edison, NJ) that monitored and 
recorded the rhodamine (R123) emission signal (503/527 nm excitation/emission wavelength) continuously over 
time (19). Briefly, a cuvette containing 1 mL of the reaction buffer (pH 7.2), R123 (200 nM), and either pyruvate 
(10 mM) + malate (5 mM) or succinate (7 mM) was placed on the stage of the fluorometer. After 2 min, 
mitochondrial protein (1 mg/mL) was added, and then once the R123 emission signal reached steady-state 
(state 2), ADP (100 or 50 μM) was added to evaluate the ADP-stimulated depolarization of Δψm. The uncoupled 
Δψm was then determined by adding carbonyl cyanide-4-(trifluoromethoxy) henylhydrazone (FCCP, 10 μM). The 
emission signal was then normalized to its final value reached after the addition of FCCP (19). 
Glutathione (GSH) content 
Lungs of randomly selected normoxia, 48-h hyperoxia, and hyperoxia + H2 rats were isolated, connected to a 
ventilation-perfusion system, and washed free of blood using Krebs–Ringer bicarbonate perfusate containing (in 
mM) 4.7 KCl, 2.51 CaCl2, 1.19 MgSO4, 2.5 KH2PO4, 118 NaCl, 25 NaHCO3, 5.5 glucose, and 5% bovine serum 
albumin as previously described (12, 20). Total lung wet weight was obtained and then a portion of the lung was 
used for the glutathione assay. The 48-h time point was chosen since at this time the increase in HMPAO lung 
uptake is large enough to evaluate the impact of H2 on GSH content without significant cellular infiltration 
observed at the 60-h time point. 
Lung tissue was dissected free from large airways and connective tissue, and weighed. The tissue was then 
placed into 10 volumes (per lung wet weight) of 4oC sulfosalicylic acid (5%), minced, and homogenized. The 
homogenate was centrifuged (10,000 × g) at 4oC for 20 min, and the supernatant was used to determine lung 
GSH content as previously described (12, 20). 
Imaging studies 
In vivo imaging studies described below were conducted on randomly selected subsets of rats from each 
exposure condition group. Sample sizes were chosen to achieve a power ≥85% using power analysis (ANOVA 
power) based on previously published means and standard deviations of the lung uptake of 99mTc-HMPAO 
and 99mTc-duramycin (11–13). 
99mTc-HMPAO and 99mTc-duramycin were constituted and labeled according to kit directions as previously 
described (11, 12), while 99mTc-macroaggregated albumin (MAA) was obtained in its labeled form. Rats were 
anesthetized with sodium pentobarbital (40–50 mg/kg, i.p.) and a femoral vein was cannulated. The rat was 
then placed supine on a plexiglass plate (4 mm) positioned directly on the face of a parallel-hole collimator (hole 
diameter = 2 mm, depth = 25 mm) attached to a modular gamma camera (Radiation Sensors, LLC) for planar 
imaging (11, 12). An injection (37–74 MBq) of 99mTc-HMPAO or 99mTc-duramycin was administered via the femoral 
vein catheter. Both agents reach steady state in the lung by 20 min postinjection, at which time a 1-min planar 
image of 99mTc-HMPAO or 99mTc-duramycin was acquired (11, 12). 
To investigate the role of the anti-oxidant GSH in the lung retention of 99mTc-HMPAO, a random subset of rats 
that were injected with 99mTc-HMPAO were then treated with DEM (1 g/kg body wt i.p.) (12). DEM depletes GSH 
by conjugating with it to form a thioether conjugate via a reaction catalyzed by the enzyme glutathione-S-
transferase (12). Forty-five minutes after DEM treatment and without relocation of the rat, a second injection 
of 99mTc-HMPAO was made and the animal reimaged 20 min later. 
Then in all rats, a final injection of 99mTc-MAA (37 MBq) was made via the same femoral cannula and the rat re-
imaged. The 99mTc-MAA injection provided a planar image in which the lung boundaries were clearly identified, 
since >95% of 99mTc-MAA lodged in the lungs. After imaging, the rats were euthanized with an overdose of 
pentobarbital. For a subset of the imaged rats, the lungs were removed, fixed inflated with paraformaldehyde, 
and then following 99mTc decay for 72 h (∼12 half-lives), used for histological studies described above. 
Image analysis 
Images were analyzed using MATLAB-based software developed in-house. The boundaries of the upper portion 
of the lungs were identified in the high-sensitivity 99mTc-MAA images and manually outlined to construct a lung 
region of interest (ROI) free of liver contribution (12). The 99mTc-MAA lung ROI mask was then superimposed on 
the 99mTc-HMPAO or 99mTc-duramycin images yielding a lung 99mTc-HMPAO or 99mTc-duramycin ROI. No 
registration was required since the animal was maintained in the same location throughout the imaging study. 
Background regions in the upper forelimbs were also identified in the 99mTc-HMPAO or 99mTc-duramycin images 
to normalize lung activity for injected 99mTc-HMPAO or 99mTc-duramycin specific activity, dose, and decay (11, 12). 
Mean counts/sec/pixel/injected dose within both the lung and forelimb-background ROIs were then determined 
and decay corrected. The ratio of the lung and background ROI signals averaged over the 15 to 20 min time 
interval, when the 99mTc-HMPAO or 99mTc-duramycin signal within the ROIs had reached steady state, was used 
as the measure of lung 99mTc-HMPAO or 99mTc-duramycin uptake (11, 12). 99mTc-HMPAO images acquired after DEM 
treatment were analyzed in the same way except that the pre-injection baseline activity level within each ROI 
was subtracted from the corresponding postinjection activity level to account for residual 99mTc-HMPAO from 
the first injection (12). 
Statistical analysis 
Statistical evaluation of data was carried out using SigmaPlot version 12.0 (Systat Software Inc, San Jose, Calif). 
The level of statistical significance was set at 0.05. Results are expressed as means ± SE unless stated otherwise. 
To evaluate differences between means of groups at different exposure times with the same treatment 
(hyperoxia, hyperoxia + DEM, hyperoxia + H2, or hyperoxia + H2 + DEM), one-way ANOVA followed by Tukey 
range test or Kruskal–Wallis one-way ANOVA on Ranks was used. To evaluate differences pre and post DEM for 
a given group, a paired two-tailed t test was used. To evaluate differences 
between hyperoxia and hyperoxia+H2 at a given exposure time, an unpaired two-tailed t test was used. For 
histology, scores of two graders were averaged, then performance of the groups compared by Kruskal–Wallis 
one-way ANOVA on Ranks. 
RESULTS 
Body weights, lung wet weight, lung wet/dry weight ratios, and pleural effusion 
Treatment with H2 had no effect on the hyperoxia-induced increase or decrease in body weight at 24 or 60 h 
(Table 2). However, the loss in body weight after 48 h of exposure was smaller (0.98 ± 0.34%) 
with hyperoxia+H2 as compared with hyperoxia alone (2.12 ± 0.32%). 
 TABLE 2. Body weight (BW) pre- and post-treatment 
Groups (n) Pre-BW (g) Post-BW (g) % change in BW 
24-h: hyperoxia (8)  346 ± 3 350 ± 3 1.04 ± 0.73 
24-h: hyperoxia + H2 (7)  347 ± 3 351 ± 3* 
(P=0.047) 
1.33 ± 0.53 
 
48-h: hyperoxia (45) 339 ± 4 332 ± 4* 
(P < 0.001) 
-2.12 ± 0.32 
 
48-h: hyperoxia + H2 
(41 
344 ± 5 
 
341 ± 5* 
(P<0.001) 
_0.98_0.34‡ 
(P = 0.018) 
60-h: hyperoxia (24) 344 ± 4 325 ± 4† 
(P < 0.001) 
-5.36 ± 0.57 
 
60-h: hyperoxia + H2 (14) 340 ± 4 
 
321 ± 4* 
(P < 0.001) 
-5.52 ± 0.64 
 
*Different from corresponding prebody weight (paired Student t test). 
†Different from corresponding prebody weight (Wilcoxon Signed Rank test). 
‡Different from 48 h hyperoxia (unpaired Student t test). 
 n indicates number of rats. 
 
Rat exposure to hyperoxia for 48 or 60 h increased left lobe wet weight/body weight ratio by 35% and 79%, 
respectively, as compared with that of normoxia rats (Table 3). Inclusion of H2 in the chamber gas mixture did 
not have a significant effect on this increase. The wet-to-dry weight ratio at 24 h was greater 
with hyperoxia+H2 than with hyperoxia alone, but not at 48 or 60 h. 
 
TABLE 3. Lung weights 
 Left lobe wet weight/body weight (mg/g) (n) Left lobe wet/dry ratio (n) 
Group   
Normoxia  1.23 ± 0.02 (18) 5.36 ± 0.07 (18) 
24-h: hyperoxia  1.22 ± 0.05 (5) 4.82 ± 0.07 (5) 
24-h: hyperoxia + H2 1.30 ± 0.03 (4) 5.31 ± 0.05† (4) 
(P = 0.001) 
48-h: hyperoxia 1.55 ± 0.07* (15) 
(P < 0.001) 
5.55 ± 0.08 (18) 
48-h: hyperoxia + H2 1.45 ± 0.04* (22) 
(P < 0.001) 
5.55 ± 0.10 (23) 
 
60-h: hyperoxia 2.16 ± 0.09* (10) 
(P < 0.001) 
5.87 ± 0.24 (12) 
 
60-h: hyperoxia + H2 
 
2.22 ± 0.14* (12) 
(P < 0.001) 
6.14 ± 0.23* (12) 
(P = 0.014) 
Kruskal–Wallis one-way ANOVA on Ranks followed by Dunn test. 
*Different from normoxia. 
†Different from 24 h hyperoxia (unpaired Student t test). 
n indicates number of rats. 
 
No measurable pleural effusion was observed in any of the groups of rats except for 60-h hyperoxia and 60-
h hyperoxia+H2. Table 4 shows that inclusion of H2 in the chamber gas mixture reduced by pleural effusion 
within the chest cavity at this time point. 
 
TABLE 4. Effect of H2 on injury endpoints 
Group  3-NT (n)  4-HNE (n) Pleural effusion (g) (n) 
Normoxia  1.0 ± 0.332 (6) 1.0 ± 0.34 (6) NG 
48-h: hyperoxia  
 
3.21 ± 0.75* (6) 
(P = 0.023) 
1.52 ± 0.47 (6) 
 
NG 
48-h: hyperoxia + H2  
 
3.07 ± 0.77* (6) 
(P ¼ 0.041) 
0.94 ± 0.28 (6) NG 
Normoxia  1.0 ± 0.113 (6) 1.0 ± 0.15 (6) NG 
60-h: hyperoxia 
 
8.87 ± 1.68*(6) 
(P = 0.002) 
1.48 ± 0.30 (6) 
 
9.3 ± 0.6 (17) 
 
60-h: hyperoxia + H2 4.25 ± 0.78*,†(6) 
*(P = 0.002) 
† (P = 0.032) 
1.62 ± 0.42 (6) 
 
2.9 ± 0.6† (15) 
(P < 0.001) 
 
3-NT and 4-HNE band density normalized to b actin and resulting values normalized to normoxia. Unpaired 
Student t test or Mann–Whitney rank sum 
test. 
*Different from normoxia. 
†Different from 60-h hyperoxia. 
n indicates number of rats; NG, negligible. 
 
Indices of oxidative stress 
Table 4 shows that expression of 3-NT, as an indicator of oxidative stress, was elevated following 60 h of 
exposure to hyperoxia alone. This increase was reduced by 50% in the animals exposed to hyperoxia+H2. The 
expression of another indicator of oxidative stress (4-HNE) was not elevated following rat exposure 
to hyperoxia or hyperoxia+H2. 
Histology 
Images of representative lung sections stained with H&E appear in Figure 1. Lung histology from rats exposed 
to hyperoxia for 24 or 48 h was indistinguishable from normoxia rats including scores for neutrophilic influx, 
edema, or thickness of the diffusion barrier (Table 5; 48 h data not shown). Samples from lungs of rats exposed 
to hyperoxia for 60 h exhibited variable degrees of edema, neutrophilic influx and, by high power, an increase in 
the width of the alveolar septum (diffusion barrier) relative to controls. Samples from rats exposed 
to hyperoxia+H2 for 60 h were not different from those of normoxia rats and were different 
from hyperoxia alone with respect to neutrophilic influx and barrier thickness. These data support protection by 
H2 relative to injury of rats exposed to 60-h hyperoxia alone. 
 FIG. 1. H&E lung slices from a normoxia rat, and from rats exposed to hyperoxia for 48 and 60 h or to 
hyperoxia H2 for 60 h. Top panels are at lower power than lower panels to facilitate assessment of neutrophilic 
influx and edema. Higher power images were used to assess thickness of the alveolar septum. H&E indicates 
hematoxylin and eosin. 
 
 
TABLE 5. H&E inflammation scores 
Group (n) Neutrophils Edema Thickness diffusion barrier 
Normoxia (4) 0 ± 0 0 ± 0 0 ± 0 
60-h: hyperoxia (5) 1.40 ± 0.16* 
(P < 0.001) 
0.33 ± 0.19 
 
1.09 ± 0.09* 
(P < 0.001) 
60-h: hyperoxia + H2 (4) 0.08 ± 0.08† 0 ± 0 0.25 ± 0.13† 
(P < 0.001) (P < 0.001) 
Kruskal–Wallis one-way ANOVA on ranks followed by Dunn test. 
*Different from normoxia. 
†Different from hyperoxia. 
H&E indicates hematoxylin and eosin; n, number of rats. 
 
BAL protein and cell counts 
Protein concentration in BAL was greater, compared with normoxic controls, in 48-h hyperoxia (150%) and 48-
h hyperoxia+H2 (63%) rats (Table 6). Total cell count in BAL was higher in 48-h hyperoxia rats than 
in hyperoxia+H2 rats (Table 6). 
 
TABLE 6. BAL protein and cell counts 
Group (n) Protein (mg/mL) Cell count (x 10 4) in collected BAL fluid 
Normoxia (6)  0.73 ± 0.03 91 ± 22 
48-h: hyperoxia (5) 1.82 ± 0.36* 
(P =0.009) 
76 ± 5 
 
48-h: hyperoxia + H2 (6) 1.19 ± 0.15* 
(P = 0.041) 
48 ± 5*,† 
*(P = 0.041),  #(P = 0.005) 
Unpaired Student t test or Mann–Whitney rank sum test. 
*Different from normoxia. 
†Different from hyperoxia. 
BAL indicates bronchoalveolar lavage; n, number of rats. 
 
Mitochondrial membrane potential (Δψm) 
We quantified ADP-stimulated depolarization of Δψm in mitochondria isolated from normoxia, hyperoxia, 
and hyperoxia+H2 rat lungs using R123. Figure 2 shows that in the presence of mitochondria and pyruvate + 
malate (complex I substrates), the addition of ADP (state 3) stimulated a transient and reversible efflux of R123 
from mitochondria, consistent with transient and reversible partial depolarization of Δψm(19). Addition of the 
mitochondrial uncoupler FCCP depolarized Δψm resulting in the maximal efflux of R123 from mitochondria (19, 21). 
Similar results were obtained with succinate (complex II substrate) as substrate. One measure of the kinetics of 
ADP-stimulated Δψm depolarization and repolarization is the full width at half maximum time (FWHM) for R123 
return to baseline (state 4), see Figure 2. Table 7 shows that rat exposure to hyperoxia for 48 h increased FWHM 
time by ∼50%. This suggests that Δψm recovery from ADP-induced depolarization in mitochondria 
from hyperoxia lungs was substantially slower than that in normoxia lungs, consistent with decreases in complex 
I and II activities in lungs of hyperoxia rats (22). Table 7 shows that the Δψm recovery time (FWHM) from ADP-
stimulated depolarization, which increased with hyperoxia, partially reversed with hyperoxia+H2, consistent with 
the ability of H2 to protect mitochondria from functional degradation by hyperoxia-induced oxidative stress. 
 
 
FIG. 2. Averaged R123 emission signal in mitochondria isolated from lungs of normoxia, 48-h hyperoxia, and 48-h 
hyperoxia+H2 rats. FWHM indicates full width, half maximum. 
 
 
 
TABLE 7. Dcm recovery time from ADP-stimulated depolarization 
Group FWHM (min) pyruvate +malate (n) FWHM (min) succinate (n) 
Normoxia 1.98 ± 0.18 (7) 1.75 ± 0.16 (6) 
48-h: hyperoxia 3.30 ± 0.29* (6) 
(P = 0.002) 
2.79 ± 0.34* (7) 
(P = 0.036) 
48-h: hyperoxia + H2 2.45 ± 0.26 (6) 1.78 ± 0.20 (6) 
Mitochondrial membrane potential 
Unpaired Student t test or Mann–Whitney Rank Sum test: *different from normoxia, n, number of rats. 
FWHM indicates full width at half maximum for 100 mM ADP-stimulated depolarization of m. 
 
Imaging results 
Lung uptake of 99mTc-HMPAO and 99mTc-duramycin was quantified from the biomarker images in groups of 
normoxia and hyperoxia rats with and without H2. Figure 3 shows representative 99mTc-HMPAO images obtained 
at steady state from a normoxia rat (left), and from rats 48 h after exposure to either hyperoxia(middle), 
or hyperoxia+H2 (right), where the lung ROI is outlined. The images show enhanced 99mTc-HMPAO uptake in the 
lungs of the hyperoxia rat, which is reduced in the hyperoxia+H2 rat. Figure 4 shows lung uptake (the ratio of 
lung-to-background signal at steady state) of 99mTc-HMPAO over 60 h of exposure to hyperoxia (filled circles) 
or hyperoxia+H2 (open circles). 99mTc-HMPAO uptake increased in a time-dependent manner, reaching a 
maximum increase of ∼270% at 60 h. At each time point, inclusion of H2 in the chamber gas mixture significantly 
reduced 99mTc-HMPAO uptake; at 60-h of exposure uptake was reduced to ∼120% of that of normoxia rats. For a 
given treatment (hyperoxia, hyperoxia +H2), one-way ANOVA followed by Tukey range test was used to evaluate 
differences between means of groups at the four exposure times. Unpaired t tests were used to evaluate 
differences between hyperoxia and hyperoxia+H2 at each time point. 
 FIG. 3. Representative planar images of 99mTc-HMPAO distribution in a normoxia (left), 48-h hyperoxia (center), 
and 48-h hyperoxia H2 (right) rat 20 min following injection. Lung ROI is determined from the 99mTc-MAA image 
with the dashed horizontal lower boundary to avoid liver contribution. 
 
 
FIG. 4. Lung uptake of 99mTc-HMPAO in rats exposed to hyperoxia (filled circles) or hyperoxia +H2 (open 
circles) for 24, 48, or 60 h. *Different from normoxia (time = 0), different from hyperoxia alone, different 
from hyperoxia pre DEM, @different from hyperoxia+H2 pre DEM, all with P < 0.001. (n) = number of rats: 
normoxia (7), normoxia + DEM (7), 24-h hyperoxia (5), 24-h hyperoxia + DEM (5), 24-h hyperoxia+H2 (7), 24-h 
hyperoxia + H2 + DEM (7), 48-h hyperoxia (5), 48-h hyperoxia +DEM (5), 
48-h hyperoxia +H2 (8), 48-h hyperoxia + H2 + DEM (5), 60-h hyperoxia (6), 60-h hyperoxia DEM (5), 60-h 
hyperoxia H2 (4), 60-h hyperoxia H2 (4). 
 
We investigated the role of GSH in 99mTc-HMPAO lung uptake by imaging rats before and after treatment with 
DEM (12). DEM treatment resulted in significantly reduced uptake in both the hyperoxia (Fig. 4, filled circles vs. 
filled triangles) and hyperoxia+H2 groups (open circles vs. open triangles), suggesting the role of GSH in the 
uptake of 99mTc-HMPAO. The reduction in 99mTc-HMPAO uptake in hyperoxia (50%) and hyperoxia+H2 (33%) rats 
was a greater fraction than that of normoxia rats (24%) (Fig. 4). For rats exposed 
to hyperoxia or hyperoxia+H2 for 24 h, the enhanced 99mTc-HMPAO lung uptake was mostly DEM-sensitive. On 
the other hand, for rats exposed to hyperoxia or hyperoxia+H2 for 48 and 60 h, only ∼50% of the measured 
increase in 99mTc-HMPAO lung uptake was DEM-sensitive. For a given treatment (hyperoxia + DEM, hyperoxia + 
H2 + DEM), one-way ANOVA followed by Tukey range test was used to evaluate differences between means of 
groups at the four exposure times. A paired t test was used to evaluate differences pre and post DEM for a given 
group. For a given exposure time, an unpaired t test was used to evaluate differences 
between hyperoxia and hyperoxia+H2. 
Figure 5 shows representative 99mTc-duramycin images at steady state obtained from a normoxia rat (left), and 
from rats 60 h after exposure to either hyperoxia (middle), or hyperoxia+H2 (right). The enhanced 99mTc-
durmaycin uptake evident in the hyperoxia rat appears reduced in the hyperoxia+H2rat. Figure 6 shows the time 
course of 99mTc-duramycin uptake in lungs of rats exposed to either hyperoxia (filled circles) 
or hyperoxia+H2 (open circles). The time-dependent increase in 99mTc-duramycin lung uptake reported 
previously with hyperoxia was reduced from ∼150% at 60 h of exposure (11) to ∼70% increase when H2 was 
included in the chamber gas mixture. For a given treatment (hyperoxia, hyperoxia +H2), one-way ANOVA 
followed by Tukey range test was used to evaluate differences between means of groups at the three exposure 
times. For a given exposure time, an unpaired t test was used to evaluate differences 
between hyperoxia and hyperoxia+H2. 
 
FIG. 5. Representative planar images of 99mTc-duramycin distribution in a normoxia (left), 60-h hyperoxia 
(center), and 60-h hyperoxia H2 (right) rat 20 min following injection. Lung ROI is determined from the 
99mTc-MAA image with the dashed horizontal lower boundary to avoid liver contribution. ROI s region of 
interest. 
 
 
FIG. 6. Lung uptake of 99mTc-duramycin in rats exposed to hyperoxia (filled circles) or hyperoxia H2 (open 
circles) for 48 or 60 h. *Different from normoxia (time 0) with P < 0.001, #different from hyperoxia alone 
with P = 0.001 for 48 h and P < 0.001 for 60 h. (n) = number of rats: normoxia (9), 48-h hyperoxia (7), 48-h 
hyperoxia +H2 (6), 60-h hyperoxia (7), 60-h hyper-oxia +H2 (5). 
 
Lung GSH content 
Table 8 shows the results of the glutathione assays indicating that rat exposure to hyperoxia increased lung 
tissue GSH content after 48 h (36%) of exposure as compared with lungs of normoxia rats. Rat exposure 
to hyperoxia+H2 for 48 h reduced that increase by 42%. Figure 7 suggests a strong relationship between GSH 
tissue content measured from lung tissue assays and in vivo99mTc-HMPAO lung uptake determined from 
imaging (12). 
 
TABLE 8. Glutathione (GSH) content of lung homogenate 
Group (n) GSH (fraction of normoxia) 
Normoxia (7) 1.00 ± 0.08 
48-h: hyperoxia (7) 1.36 ± 0.02* 
(P < 0.001)* 
48-h: hyperoxia + H2 (6) 1.21 ± 0.003 
*,† 
(P <0.001)* 
(P <0.001)† 
GSH concentration for normoxia lungs was 9.02±0.38 (n¼7) mmol/g dry wt.  
Unpaired Student t test: *different from normoxia, †different from hyperoxia.  
n indicates number of rats. 
 
Fig. 7. Relationship between 99mTc-HMPAO lung uptake (Fig. 4 and lung tissue GSH content (as fraction of 
normoxia, Table 8). GSH indicates glutathione. 
DISCUSSION AND CONCLUSIONS 
The present study detects and tracks the anti-oxidant and anti-apoptotic properties of H2 therapy in vivo and to 
demonstrate protection after as early as 24 h of hyperoxia exposure. The results demonstrate the ability of the 
two molecular biomarkers 99mTc-HMPAO and 99mTc-duramycin to quantify lung injury and the response to 
H2 treatment in vivo in rats exposed to hyperoxia as a model of human ALI/ARDS. Smaller increases in the lung 
uptake of both 99mTc-HMPAO and 99mTc-duramycin over the 60-h exposure period were observed in rats exposed 
to hyperoxia+H2 as compared with rats exposed to hyperoxia alone. These results are consistent with the anti-
oxidant, anti-apoptotic, and anti-inflammatory properties of H2(5–9). They are also in agreement with our 
observations of decreased injury severity in H2 treated rats based on lung histology and lavage constituents, 
pleural effusion, and less mitochondrial dysfunction as identified by kinetic responses of isolated mitochondria. 
99mTc-HMPAO was originally developed as a brain perfusion agent but its uptake and retention in several tissues 
serve as a marker of tissue redox state (23). 99mTc-HMPAO reduction and thus its cellular retention has been 
shown to be strongly dependent on the oxidoreductive state of the tissue including intracellular GSH content 
and other factors involving mitochondrial redox state (12). Recently, we demonstrated a strong correlation 
between 99mTc-HMPAO lung uptake and lung tissue GSH content (12). The results of the current study (Fig. 4) 
show that 99mTc-HMPAO lung uptake increased steadily over the 60-h hyperoxia exposure period, and that most 
of the increase was DEM-inhabitable or GSH-dependent, consistent with lung tissue response to hyperoxia-
induced oxidative stress. 
On the other hand, exposure to hyperoxia+H2 decreased 99mTc-HMPAO lung uptake in comparison to lung 
uptake in rats exposed to hyperoxia alone, and most of the decrease was in the GSH-dependent component. 
Since antioxidants such as GSH increase in response to oxidative stress, the effect of H2 on the DEM-sensitive 
portion of 99mTc-HMPAO lung uptake and on the GSH content of lung homogenate suggests that H2 treatment 
reduced hyperoxia-induced oxidative stress. This is reflective of H2's anti-oxidant properties and consistent with 
its ability to mitigate the hyperoxia-induced increase in 3-NT expression in our studies (Table 4). Sun et 
al. (9) showed that rat exposure to hyperoxia for 60 h increased lung tissue superoxide dismutase (SOD) activity 
compared with that of normoxia rats, and that the increased SOD activity was smaller in lungs of hyperoxia-
exposed rat that received multiple intraperitoneal injections of H2-rich saline during the exposure period. In that 
study, the anti-oxidant properties of H2 were reflected by its ability to mitigate hyperoxia-induced increase in 
lung tissue lipid and DNA oxidation (Table 9). Kawamura et al. (5) suggested that the H2 protective effect is via the 
induction of the nuclear factor erythroid two-related factor antioxidant response element (Nrf2-ARE) signaling 
pathway. They showed that the expressions of Nrf2-ARE dependent enzymes, including heme oxygenase (HO-1), 
increased more in lungs of rats exposed to hyperoxia+H2 for 60 h than in lungs of rats exposed 
to hyperoxia alone (5). HO-1 is important for removing free heme, a source of iron which plays a key role in 
hydroxyl radical formation via the Fenton reaction (5). Although the exact mechanism by which H2 exerts its anti-
oxidant properties is still not fully understood, the results of current and previous studies suggest that the 
mechanism could be either by directly scavenging hydroxyl radical via an exothermic reaction (8) and/or 
indirectly by its effect on the expression of HO-1 (5). 
 TABLE 9. Summary of effects of rat exposure to hyperoxia + H2 for 60 h compared with exposure to hyperoxia 
alone for 60 h on various antioxidant enzymes and indices of lung injury 
 Kawamura et al. 2013 Sun et al. 2011 Current study Rat 
Rat strain  Adult Lewis (male) Adult SD (male) Adult SD (male) 
H2 delivery  2% H2 gas (inhaled) Saline-rich H2 (i.p.) 2% H2 gas (inhaled) 
Body weight loss  Lower NA NS 
Lung wet weight                                                                                                NA NA NS 
Lung wet/dry                                                                    -8% -7% +5% 
Pleural effusion                                                               -40% -30% -70% 
SOD                                                                                   NA -40% NA 
3-NT                                                                                  NA NA -51% 
4-HNE  NA NA NS 
BAL protein                                                                     -46% NA NA 
H&E score  Lower Lower Lower 
Apoptosis                                                                        -31% -33% -53% 
Pro-inflammatory cytokines  Lower Lower NA 
MDA                                                                                   NA -40% NA 
8-OHdG                                                                                      NA -49% NA 
HO-1 expression  +136% NA NA 
NQO1 expression  +93% NA NA 
GSTA2 expression  +158% NA NA 
Prdx1 expression  +105% NA NA 
8-OHdG indicates 8-hydroxy-2’ -deoxyguanosine; GSTA2, glutathione S-transferase A2; MDA, malondialdehyde; 
NA, not available; NS, not significant; 
Prdx1, peroxiredoxin 1; SOD, superoxide dismutase. 
 
The increase in GSH content of lung homogenate (+36% for 48-h hyperoxia and +21% for 48-
h hyperoxia+H2 compared with normoxia) is lower than the ∼100% to 170% increase in HMPAO lung uptake 
measured from the in vivo images and the ∼50% to 280% increase in the DEM-sensitive portion of the HMPAO 
lung uptake. One explanation for this difference could be the fact that the GSH content reported in this study is 
the average GSH content of all lung cells and alveolar fluid. Although the results of this study do not provide 
information regarding the specific types of lung cells contributing to the lung uptake and retention of HMPAO, 
previous studies have suggested that its retention is predominantly attributable to endothelial cells (24, 25), which 
account for ∼50% of lung cells and are in direct contact with blood (4). Other studies have also demonstrated 
that different cell types have different GSH content, and oxidant stress has different effects on the GSH content 
of these cells (26, 27). For instance, Deneke et al. (26) demonstrated that exposure of endothelial cells 
to hyperoxia (85% O2 for 48 h) increased GSH content by 85%. On the other hand, neutrophil GSH content is not 
sensitive to oxidant injury (27). Thus, depending on the GSH content of the various lung cells and how the GSH 
content of these cells change in response to exposure to hyperoxia, the GSH content in lung homogenate 
measured in this study may overestimate or underestimate the effect of hyperoxia or hyperoxia+H2 on GSH 
content of pulmonary capillary endothelial cells. 
99mTc-duramycin serves as a molecular probe that binds to phosphatidylethanolamine, which has little presence 
on the surface of normal viable cells, but becomes exposed onto the cell surface and/or accessible to the 
extracellular milieu with apoptosis and necrosis, respectively (11, 28). Previously, we reported an increase in the 
lung uptake of 99mTc-duramycin in rats exposed to hyperoxia or radiation, and demonstrated a strong correlation 
between 99mTc-duramycin lung uptake and cleaved caspase 3 positive cells, predominantly endothelial cells (11, 
14). Figure 6 shows that 99mTc-duramycin lung uptake was significantly lower in lungs of rats exposed 
to hyperoxia+H2 as compared with that in lungs of rats exposed to hyperoxiaalone (11), reflective of the anti-
apoptotic properties of H2(5, 8, 9). This result is consistent with those reported by others (Table 9). For instance, 
Sun et al. (9) reported that H2 treatment mitigated hyperoxia-induced increases in TUNEL positive lung cells. 
Kawamura et al. (5) demonstrated the ability of H2 to protect against hyperoxia-induced increases in the number 
of caspase 3 positive lung cells. Additional results show that H2inhibited hyperoxia-induced increases in the 
expression of the anti-apoptotic protein Bcl-2 and decreases in the expression of the pro-apoptotic protein 
Bax (5). Dixon et al. (8) suggested that H2's anti-apoptotic effect is via its ability to inhibit the activation of caspase-
3. 
The anti-inflammation properties of H2 are reflected in the histological (Fig. 1) and BAL (Table 6) results, which 
show less cellular infiltration in lungs of rats exposed to hyperoxia+H2 compared with those exposed 
to hyperoxia. These results are consistent with other studies (Table 9) that demonstrated the ability of H2 to 
mitigate hyperoxia-induced increases in BAL protein, histology, and levels of pro-inflammatory cytokines in lung 
tissue (5, 9). 
Isolated mitochondria studies using R123 (Fig. 2, Table 7) suggest the ability of H2 to provide mitochondrial 
electron transport chain with partial protection from hyperoxia-induced oxidative stress. We previously 
demonstrated significant decreases in complex I and II activities in lung of rats exposed to hyperoxia for 48 h (22). 
Mitochondrial DNA (mtDNA) is highly sensitive to reactive oxygen species (ROS) (29). A hyperoxia-induced 
increase in the rate of ROS formation could damage mtDNA and as a result compromise complex I activity since 
7 of 45 subunits of complex I are encoded by mtDNA (29, 30). This increase in ROS formation could also cause 
direct alteration to complex I activity by oxidizing the key phospholipid cardiolipin, which is sensitive to ROS (31, 
32). Oxidation of cardiolipin could lead to an increase in the loss of electrons at complex I and in the rate of 
mitochondrial superoxide formation at complex I (31, 32). Furthermore, cardiolipin oxidation can affect complex II 
since it is required for its optimal activity and stability (33). Our results (Fig. 2, Table 7) using R123 suggest that 
H2 partially protected complex I and II activities from oxidative stress. 
In the present study, the effect of H2 on hyperoxia-induced body weight loss and increase in lung wet/dry weight 
ratio after 60 h of exposure (Tables 2 and 3) are not consistent with those reported by other studies (Table 9). 
For instance, both Sun et al. and Kawamura et al. reported lower lung wet/dry weight ratios in rats treated 
with hyperoxia+H2 as compared with rats treated with hyperoxia (5, 9). In addition, Kawamura et al. (5)reported 
that H2 reduced rat body weight loss after 60 h of exposure to hyperoxia. The difference between these results 
and results of the current study could be due to differences in rat strains (Sprague–Dawley vs. Lewis rats in 
Kawamura et al. (5)) or in H2 administration (intraperitoneal injection of H2-rich saline in Sun et al. (9)). Xie et 
al. (10) showed that the protective effects of H2 against sepsis-induced lung injury are dose dependent over 1% to 
4% range. Thus, additional protection might be observed in Sprague–Dawley rats with higher concentrations of 
H2 than the 2% used in the present study. 
Several gaseous therapies have been evaluated for hyperoxia-induced ALI/ARDS, including nitric oxide (NO), 
carbon monoxide (CO), and H2(8, 34, 35). Like NO and CO, H2 is highly permeable across various cellular barriers and 
hence capable of accessing key cellular compartments such as mitochondrion which appear to play a key role in 
the pathogenesis of human ALI/ARDS. However, H2 is advantageous since it does not affect the physiological or 
immune response of key ROS (superoxide and hydrogen peroxide). Moreover, H2 is not toxic at high 
concentrations and is safe at concentrations < 4.1% when mixed with O2(8). 
In conclusion, the results suggest the potential translational utility of imaging with two SPECT biomarkers, one of 
which is already in clinical use, for in vivo assessment of key cellular pathways involved in the pathogenesis of 
ALI/ARDS and for monitoring responses to potential therapies such as inhaled H2 gas. 
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